Patient Support | Amylyx
Patient Support | Amylyx
Description: RELYVRIO™ is an FDA-approved, oral fixed-dose combination treatment for adults living with ALS, shown to help slow the loss of physical function.
Slow functional decline. Help extend independence. 1 RELYVRIO TM is an FDA-approved, oral fixed-dose combination treatment for adults living with amyotrophic lateral sclerosis (ALS), shown to help slow the loss of physical function, which may help extend independence. 1
RELYVRIO TM is an FDA-approved, oral fixed-dose combination treatment for adults living with amyotrophic lateral sclerosis (ALS), shown to help slow the loss of physical function, which may help extend independence. 1
Mean als functional rating scale-revised score was
Patient Support | Amylyx
Patient Support | Amylyx